Get access

p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome

Authors

  • Edoardo Pescarmona,

    Corresponding author
    1. II Cattedra di Anatomia ed Istologia Patologica, Dipartimento di Medicina Sperimentale e Patologia, Università degli Studi ‘La Sapienza’, Roma, Italy
    • Dipartimento di Medicina Sperimentale e Patologia,Policlinico Umberto I, Viale Regina Elena, 324 00161 Rome, Italy.
    Search for more papers by this author
  • Patrizia Pignoloni,

    1. Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi ‘La Sapienza’, Roma, Italy
    Search for more papers by this author
  • Maria Puopolo,

    1. Section of Comparative Psychology, Laboratorio di Fisiopatologia di Organo e di Sistema, Istituto Superiore di Sanità, Roma, Italy
    Search for more papers by this author
  • Maurizio Martelli,

    1. Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi ‘La Sapienza’, Roma, Italy
    Search for more papers by this author
  • Maria Addesso,

    1. II Cattedra di Anatomia ed Istologia Patologica, Dipartimento di Medicina Sperimentale e Patologia, Università degli Studi ‘La Sapienza’, Roma, Italy
    Search for more papers by this author
  • Cesare Guglielmi,

    1. Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi ‘La Sapienza’, Roma, Italy
    Search for more papers by this author
  • Carlo D. Baroni

    1. II Cattedra di Anatomia ed Istologia Patologica, Dipartimento di Medicina Sperimentale e Patologia, Università degli Studi ‘La Sapienza’, Roma, Italy
    Search for more papers by this author

Abstract

Peripheral T-cell lymphomas (PTCL) are usually characterized by aggressive clinical behaviour and poor clinical outcome, but their biological background has not been extensively investigated to date, due to their low incidence, about 10% of all non-Hodgkin's lymphoma cases in Western countries, and also to the paucity of specific molecular-genetic abnormalities. Neverthless, there is increasing biological and clinical evidence that primary nodal PTCL should be considered separately from extra-nodal cases, but little is known about biological factors of possible clinical and prognostic impact. This immunohistochemical study has analysed the expression of p53, Mdm2, p21WAF1, BCL-2 and p-glycoprotein (MDR-1 gene product) in a series of 45 cases of nodal peripheral T-cell lymphomas (PTCL) with ‘high-grade’ histology. The immunohistochemical findings were then correlated with proliferative activity and clinical outcome. p53 was over-expressed in 13 cases (28.9%). p53 positive cases showed significantly higher proliferative activity (p<0.01), more frequent expression of Bcl-2 (p<0.01) and less frequent expression of p21WAF1 than p53 negative cases. Mdm2 and p-glycoprotein were expressed in 4/13 (30.8%) and 8/13 (61.5%) p53 positive cases respectively, and in none (0%) of the p53 negative cases (p<0.01). Analysis of the survival curves showed that p53 positive cases were associated with a significantly poorer clinical outcome than p53 negative cases, in terms of both overall survival (p=0.0032) and event-free survival (p=0.0004). Furthermore, multivariate analysis showed that p53 expression was the most important independent prognostic variable. These findings indicate that p53 over-expression identifies a subset of nodal PTCL cases with a distinctive biological profile (higher proliferative activity, less frequent expression of p21WAF1 and more frequent expression of Bcl-2, Mdm2 and p-glycoprotein than p53 negative cases) and poor clinical outcome. The immunohistochemical analysis of p53 expression is a simple, rapid and low-cost method which may provide information of potential clinical and prognostic value in nodal peripheral T-cell lymphomas. Copyright © 2001 John Wiley & Sons, Ltd.

Ancillary